Revised: Bedrocan Cannabis Corp. (TSX.V:BED) CED Marc Wayne Interviewed on Midas Letter CEO Podcast

Bedrocan Cannabis Corp.

Healthcare & Pharmaceutical

Share Tweet

Revised: Bedrocan Cannabis Corp. (TSX.V:BED) CED Marc Wayne Interviewed on Midas Letter CEO Podcast

Toronto, ON / ACCESSWIRE / August 27, 2014 / Bedrocan Cannabis Corp. (TSX.V:BED) CEO Marc Wayne joins James West of for a 17 minute interview in which Marc discusses Bedrocan's superior value proposition for investors, and how his role as Chairman of the Canadian Medical Cannabis Industry Association gives him unique insights into the nascent Marihuana for Medical Purposes Regulations governing the industry via Health Canada.

"Bedrocan is the most trusted and credible name in medicinal cannabis worldwide," said Wayne during the interview. "We produce a pharmaceutical grade quality product where we stand behind our product. I think product quality is the most important aspect of this."

Listen to the full interview here:

Or read the full transcript of the interview here:

About Bedrocan Cannabis Corp.

Bedrocan is the most experienced, research-centered producer of pharmaceutical-grade medicinal cannabis in the world, with a mission to provide patients and healthcare professionals with safe, effective and consistent medicine for the appropriate management of diagnosed health conditions.


Midas Letter is the global investment journal of emerging companies with 'best-in-class' potential across all sectors. MidasLetter's James West has been at the forefront of the emerging company sector since founding the letter in 2008.

MidasLetter provides subscribers with advanced market intelligence on new issuers, and focuses on identifying only those with the potential to become industry leaders in their respective sectors.

Visit to learn more.


SOURCE: Bedrocan Cannabis Corp.